MEND-CABG MC-1

· Medicure

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MEND-CABG MC-1, covering 2006-10-31 to 2006-10-31. Get the full timeline:

Most recent: Clinical Trial Update: MEND-CABG (MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery) [Phase 2]